Paper19104016
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
Hirt D and 13 others. Antimicrob Agents Chemother, 2009. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Papers, record 19104016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19104016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| Deoxycytidine | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Infant, Newborn | Major topic |
| Pregnancy Complications, Infectious | Major topic |
| Adenine | |
| Area Under Curve | |
| Clinical Trials as Topic | |
| Emtricitabine | |
| Female | |
| Half-Life | |
| Humans | |
| Maternal-Fetal Exchange | |
| Organophosphonates | |
| Population Groups | |
| Pregnancy | |
| Prenatal Exposure Delayed Effects | |
| Tenofovir |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00334256 | Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) | Results |
Source ClinicalTrials.gov
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17414929 | Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. | J Acquir Immune Defic Syndr | 2007 | https://conductscience.org/library/papers/17414929 | PubMed |
| 2 | 15942891 | Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15942891 | PubMed |
| 3 | 10558940 | Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants. | J Infect Dis | 1999 | https://conductscience.org/library/papers/10558940 | PubMed |
| 4 | 7413726 | Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. | Pharmacol Ther | 1980 | https://conductscience.org/library/papers/7413726 | PubMed |
| 5 | 11768292 | Ways to fit a PK model with some data below the quantification limit. | J Pharmacokinet Pharmacodyn | 2001 | https://conductscience.org/library/papers/11768292 | PubMed |
| 6 | 17519400 | Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. | J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17519400 | PubMed |
| 7 | 5473321 | Transit time in the small intestine in pregnancy. | J Obstet Gynaecol Br Commonw | 1970 | https://conductscience.org/library/papers/5473321 | PubMed |
| 8 | 18325857 | Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry. | J Chromatogr B Analyt Technol Biomed Life Sci | 2008 | https://conductscience.org/library/papers/18325857 | PubMed |
| 9 | 14693538 | Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14693538 | PubMed |
| 10 | 9391746 | Pharmacokinetic changes during pregnancy and their clinical relevance. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9391746 | PubMed |
| 11 | 17526857 | Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers. | J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17526857 | PubMed |
| 12 | 11131716 | Antiretroviral pharmacology in pregnant women and their newborns. | Ann N Y Acad Sci | 2000 | https://conductscience.org/library/papers/11131716 | PubMed |
| 13 | 17997151 | Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. | Lancet | 2007 | https://conductscience.org/library/papers/17997151 | PubMed |
| 14 | 10983633 | Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. | AIDS | 2000 | https://conductscience.org/library/papers/10983633 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687587 | Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42687587 | PubMed |
| 40733121 | Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733121 | PubMed |
| 37830105 | Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy. | Front Reprod Health | 2023 | https://conductscience.org/library/papers/37830105 | PubMed |
| 37814498 | A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37814498 | PubMed |
| 35067869 | Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35067869 | PubMed |
| 34733804 | Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics? | Front Pediatr | 2021 | https://conductscience.org/library/papers/34733804 | PubMed |
| 33527213 | Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/33527213 | PubMed |
| 31602556 | Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment. | Drugs R D | 2019 | https://conductscience.org/library/papers/31602556 | PubMed |
| 31160284 | Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31160284 | PubMed |
| 29894385 | Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis. | AIDS | 2018 | https://conductscience.org/library/papers/29894385 | PubMed |
| 28426519 | Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding. | Curr Opin HIV AIDS | 2017 | https://conductscience.org/library/papers/28426519 | PubMed |
| 27766562 | A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/27766562 | PubMed |
| 27676257 | Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. | PLoS Med | 2016 | https://conductscience.org/library/papers/27676257 | PubMed |
| 26518984 | Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26518984 | PubMed |
| 26011128 | Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/26011128 | PubMed |
| 25223699 | Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/25223699 | PubMed |
| 24995851 | Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24995851 | PubMed |
| 24844642 | Pharmacokinetic studies in infants using minimal-risk study designs. | Curr Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24844642 | PubMed |
| 24492366 | Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24492366 | PubMed |
| 23179579 | Population pharmacokinetic analysis during the first 2 years of life: an overview. | Clin Pharmacokinet | 2012 | https://conductscience.org/library/papers/23179579 | PubMed |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| TENOFOVIR DISOPROXIL FUMARATE | CHEMBL1486 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1486 | ChEMBL |
| EMTRICITABINE, (+/-)- | CHEMBL161381 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL161381 | ChEMBL |
| EMTRICITABINE | CHEMBL885 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL885 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19104016
GET https://conductscience.org/api/papers/v1/19104016/cited_by?page=2